Загрузка...
Laboratory Monitoring of Chronic Myeloid Leukemia in Patients on Tyrosine Kinase Inhibitors
Chronic Myeloid Leukemia (CML) is a myeloproliferative neoplasm characterized by translocation of genetic material from chromosome 9 to chromosome 22 to form a fusion gene (BCR-ABL1) that is responsible for abnormal tyrosine kinase activity and alteration of various downstream signaling pathways. In...
Сохранить в:
| Опубликовано в: : | Indian J Hematol Blood Transfus |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer India
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5885003/ https://ncbi.nlm.nih.gov/pubmed/29622860 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12288-018-0933-1 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|